USP19 Inhibits TNF-α– and IL-1β–Triggered NF-κB Activation by Deubiquitinating TAK1

作者：Cao‐Qi Lei, Xin Wu, Xuan Zhong, Lu Jiang, Bo Zhong, Hong‐Bing Shu · 发表于：The Journal of Immunology · 年份：2019 · DOI：10.4049/jimmunol.1900083 · 被引用次数：122 · 研究领域：NF-κB Signaling Pathways、Ubiquitin and proteasome pathways、interferon and immune responses

Abstract The dynamic regulations of ubiquitination and deubiquitination play important roles in TGF-β–activated kinase 1 (TAK1)-mediated NF-κB activation, which regulates various physiological and pathological events. We identified ubiquitin-specific protease (USP)19 as a negative regulator of TNF-α– and IL-1β–triggered NF-κB activation by deubiquitinating TAK1. Overexpression of USP19 but not its enzymatic inactive mutant inhibited TNF-α– and IL-1β–triggered NF-κB activation and transcription of downstream genes, whereas USP19 deficiency had the opposite effects. Usp19−/− mice produced higher levels of inflammatory cytokines and were more susceptible to TNF-α– and IL-1β–triggered septicemia death compared with their wild-type littermates. Mechanistically, USP19 interacted with TAK1 in a TNF-α– or IL-1β–dependent manner and specifically deconjugated K63- and K27-linked polyubiquitin chains from TAK1, leading to the impairment of TAK1 activity and the disruption of the TAK1–TAB2/3 complex. Our findings provide new insights to the complicated molecular mechanisms of the attenuation of the inflammatory response.